Esperion Therapeutics Inc

NASDAQ: ESPR
$2.52
+$0.05 (+1.8%)
Real Time Data Delayed 15 Min.

ESPR Stock Chart and Intraday Price

ESPR Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 471.89M USD
Shares Outstanding 185,053,000
Esperion Therapeutics is a pharmaceutical company focused on creating medicines to help patients manage elevated low density lipoprotein cholesterol, a key factor in heart disease. Its main products, NEXLETOL and NEXLIZET, are designed for individuals with cardiovascular issues or specific genetic cholesterol conditions. Based in Ann Arbor, Michigan, and founded in 2008, Esperion also collaborates with other firms to expand its portfolio, including working on an innovative oral treatment for cholesterol management.

ESPR Articles

Monday's Top Analysts Upgrades and Downgrades: Block, Broadcom, CarMax, Deere, Marvell Technology, MGM Resorts, Moderna, Newmont and More
Monday's top analyst upgrades and downgrades included Block, Broadcom, CarMax, Deere, Esperion Therapeutics, Marvell Technology, MGM Resorts International, Moderna, Newmont, Vipshop and Wingstop.
Lee Jackson
Published:

Will July's Employment Report Make or Break? Analysts Upgrade or Downgrade PayPal, XPeng and More
Wednesday's additional top analyst upgrades and downgrades included CF Industries, Cognex, Incyte, PayPal, XPeng and Xylem.
Chris Lange
Published:

Monday's Top Analyst Upgrades and Downgrades: Apple, AT&T, Chevron, Dollar General, Ford, Kroger, Marvell, Peloton, Salesforce, Twitter and More
Monday’s top analyst upgrades and downgrades included Amgen, Apple, AT&T, Chevron, Dollar General, Fastly, Ford, Hertz, Kroger, Marvell Technology, Peloton Interactive, Salesforce.com, Stitch Fix...
Lee Jackson
Published:

Tuesday Afternoon Analyst Upgrades and Downgrades: CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and More
Tuesday afternoon's analyst upgrades and downgrades included CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and more.
Chris Lange
Published:

Wednesday's Top Analyst Upgrades and Downgrades: Clorox, Conoco, Exxon, Kraft Heinz, Nvidia, Under Armour and More
Wednesday's top analyst upgrades and downgrades included Clorox, ConocoPhillips, Exxon Mobil, Ferrari, Kraft Heinz, Nvidia and Under Armour.
Lee Jackson
Published:

Alexion, Activision, Baker Hughes and More Monday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.
Chris Lange
Published:

AEP, Oracle, Tesla and More Thursday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including American Electric Power, Keurig Dr Pepper, Oracle, Restaurant Brands, Tesla and more.
Chris Lange
Published:

Top Analyst Upgrades and Downgrades: Bilibili, Constellation Brands, FedEx, Harley-Davidson, Matador Resources, Twilio, Yandex and More
Tuesday's top analyst upgrades and downgrades included Bilibili, Constellation Brands, FedEx, Harley-Davidson, Matador Resources, Twilio and Yandex.
Lee Jackson
Published:

Top Analyst Upgrades and Downgrades: Bed Bath & Beyond, Booking, Carvana, EA, EOG, Honeywell, ICE, Livongo, Nucor, Seres, Sunrun and More
Tuesday's top analyst upgrades and downgrades included Bed Bath & Beyond, Booking, Carvana, Electronic Arts, EOG Resources, Honeywell, Intercontinental Exchange, Livongo Health, Nucor, Seres...
Jon C. Ogg
Published:

Top Analyst Upgrades and Downgrades: Aimmune, Apple, Aurora Cannabis, Dick's, Halliburton, HP, JPMorgan, Lowe's, Lyft, Schlumberger, Uber and More
The top analyst upgrades, downgrades and initiations for Monday included Aimmune Therapeutics, Apple, Aurora Cannabis, Dick's Sporting Goods, Halliburton, HP, JPMorgan, Lowe's, Lyft, Schlumberger and...
Jon C. Ogg
Published:
Last Updated: